LEADER 01186nam 2200421 450 001 9910162798203321 005 20230808201349.0 010 $a1-936277-77-8 035 $a(CKB)3710000001033321 035 $a(MiAaPQ)EBC4791049 035 $a(EXLCZ)993710000001033321 100 $a20170214h20162016 uy| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aActive pieces /$fJay Bonin and Greg Keener 205 $aFirst English edition. 210 1$aBoston :$cMongoose Press,$d[2016] 210 4$d©2016 215 $a1 online resource (454 pages) $cillustrations 300 $aIncludes index. 311 $a1-936277-76-X 517 1 $aActive pieces :$epractical advice from America's most relentless tournament player 606 $aChess 606 $aChess$xStudy and teaching 615 0$aChess. 615 0$aChess$xStudy and teaching. 700 $aBonin$b Jay$01377189 702 $aKeener$b Greg 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910162798203321 996 $aActive pieces$93413934 997 $aUNINA LEADER 01005nam0 22002771i 450 001 UON00023026 005 20231205102027.306 010 $a99-637-5156-3 100 $a20020107d1991 |0itac50 ba 101 $aeng 102 $aCY 105 $a|||| 1|||| 200 1 $aCyprus and the European Community 210 $aNicosia$cEuroconsult LTD$d1991 215 $a179 p.$ctav.rip. f.t.$d22 cm 606 $aCIPRO$xRapporti con la CEE$3UONC011025$2FI 606 $aEconomia$xCipro$xSec. 20.$3UONC011026$2FI 620 $dNicosia$3UONL001030 686 $aCYP XII$cCIPRO - ECONOMIA$2A 712 $aEuraconsult LTD$3UONV249563$4650 801 $aIT$bSOL$c20250704$gRICA 899 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI 912 $aUON00023026 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI TUR XII 028 N $eSI SA 82080 5 028 N 996 $aCyprus and the European Community$91199437 997 $aUNIOR LEADER 04429nam 2201021z- 450 001 9910557644303321 005 20220111 035 $a(CKB)5400000000045010 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76776 035 $a(oapen)doab76776 035 $a(EXLCZ)995400000000045010 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aCrocus sativus L. Extract and Its Constituents: Chemistry, Pharmacology and Therapeutic Potential 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (171 p.) 311 08$a3-0365-1806-1 311 08$a3-0365-1805-3 330 $aNatural products or organic compounds isolated from natural sources as primary or secondary metabolites have inspired numerous drugs. It is not an overstatement that the majority of medicines in clinics, even in the 21st century, have been derived from natural resources despite the decline of industry research into natural products due to a variety of drawbacks. Saffron crocus, considered to be the most valuable spice by weight, and its bioactive constituents, have been studied for the treatment of a wide range of pathologies, including neuropsychiatric and neurodegenerative disorders, cancer, diabetes, and even cardiovascular diseases. In this book on the chemistry, pharmacology, and therapeutic potential of Crocus sativus L. extract and its constituents, we aimed to assess new advances in the understanding of the therapeutic action of saffron and its constituents in targeting different pathologies. In this context, eight original research articles covering recent advances in the therapeutic actions of saffron and its ingredients in different diseases are reported. Two studies reporting novel methods regarding the bioanalysis of saffron extracts have been included. The collection is completed with two very interesting reviews reporting advances in the fields of schizophrenia and cancer. In conclusion, in this book, we are delighted to have received several contributions that we hope will provide new and interesting information for the scientific community on the chemistry, pharmacology, and therapeutic potential of Crocus sativus L. extract and its constituents. 517 $aCrocus sativus L. Extract and Its Constituents 606 $aMedicine and Nursing$2bicssc 610 $aaffron® 610 $aanesthetic ketamine 610 $aanticancer activity 610 $aantioxidant 610 $aanxiety 610 $aapoptosis 610 $aautophagy 610 $acancer 610 $achemoprevention 610 $aclinical trials 610 $acolitis 610 $acolorectal cancer 610 $acrocetin 610 $acrocin 610 $acrocins 610 $aCrocus sativus 610 $aCrocus sativus L. 610 $aCrocus sativus L. (Iridaceae) 610 $acytokines 610 $adepression 610 $adietary supplement 610 $aDNA damage and repair 610 $afertility preservation 610 $aflumazenil 610 $afraction 610 $aglucose 610 $agut microbiota 610 $aHCT116 610 $aHR MS 610 $aHuR 610 $ainflammatory bowel disease 610 $ainsulin 610 $amemory 610 $ametabolomics 610 $aMLH1 610 $aMSH3 610 $an/a 610 $aneuroprotective activity 610 $anutraceutical 610 $aoxidative stress 610 $aP2X7 receptor 610 $apatents 610 $apck1 610 $apicrocrocin 610 $apubertal testis 610 $aradiotherapy 610 $arat 610 $areversed-phase UPLC 610 $asaffron 610 $asafranal 610 $aschizophrenia 610 $aSIRT1 610 $aX-rays 610 $a?-pancreatic cells 615 7$aMedicine and Nursing 700 $aPitsikas$b Nikolaos$4edt$01332364 702 $aDimas$b Konstantinos$4edt 702 $aPitsikas$b Nikolaos$4oth 702 $aDimas$b Konstantinos$4oth 906 $aBOOK 912 $a9910557644303321 996 $aCrocus sativus L. Extract and Its Constituents: Chemistry, Pharmacology and Therapeutic Potential$93040891 997 $aUNINA